OT 15

Drug Profile

OT 15

Alternative Names: EE-TP; Erythrocyte Encapsulated Thymidine Phosphorylase; OT-15

Latest Information Update: 28 Jul 2016

Price : $50

At a glance

  • Originator Orphan Technologies
  • Class Enzymes
  • Mechanism of Action Enzyme replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Metabolic disorders
  • New Molecular Entity Yes

Highest Development Phases

  • Clinical Phase Unknown Metabolic disorders

Most Recent Events

  • 28 Jul 2016 OT 15 is still available for compassionate use in United Kingdom
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top